Aug 2 (Reuters) - Medical device company CryoCor Inc. said the U.S. Food and Drug Administration has granted pre-market approval for its device for the treatment of right atrial flutter, or abnormal ...
June 28 (Reuters) - Boston Scientific Corp. and CryoCor Inc. said they entered a deal to co-develop therapies for atrial fibrillation -- abnormal beating of the heart's upper chambers. CryoCor's ...
SAN FRANCISCO (MarketWatch) -- CryoCor Inc. said after the closing bell on Thursday it has received notification from the Food and Drug Administration that its pre-market approval application for the ...